Clinical Trials Logo

Clinical Trial Summary

A quasi-experimental study will compare primary health care-based prevention and management of alcohol use disorder, operationalized by heavy drinking, in three intervention cities from Colombia, Mexico and Peru with three comparator cities from the same countries. In the implementation cities, primary health care units (PHCUs) will receive training embedded within ongoing supportive municipal action over an 18-month implementation period. In the comparator cities, practice as usual will continue at both municipal and PHCU levels. The primary outcome will be the proportion of consulting adult patients intervened with (screened and advice given to screen positives).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03524599
Study type Interventional
Source Maastricht University
Contact Peter Anderson, MD, PhD
Phone +34 618075217
Email peter.anderson@maastrichtuniversity.nl
Status Not yet recruiting
Phase N/A
Start date June 1, 2018
Completion date June 30, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT03406039 - Testing the Efficacy of an Online Integrated Treatment for Comorbid Alcohol Misuse and Emotional Problems N/A
Not yet recruiting NCT03530384 - Training Inhibition in Alcohol Use Disorder N/A
Completed NCT03573167 - Mobile Phone-Based Motivational Interviewing in Kenya N/A
Not yet recruiting NCT03652675 - Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV N/A
Not yet recruiting NCT03662737 - VRT as a Biomarker of Cerebellar Dysfunction in Chronic Cannabis Use
Recruiting NCT02994043 - Alcohol, Inflammation, and Mindfulness Study N/A
Recruiting NCT02884908 - Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD Phase 3
Enrolling by invitation NCT02544581 - Preliminary Analysis of the Soberlink Alcohol Breath Analyzer System's (SABA) Clinical Utility During Aftercare N/A
Completed NCT02511886 - A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder Phase 2
Active, not recruiting NCT02185131 - Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD. Phase 2
Completed NCT01916941 - Neural Mechanisms of Change During the Treatment of Alcohol Use Disorders With Prazosin N/A
Terminated NCT01408641 - Topiramate for Alcohol Use in Posttraumatic Stress Disorder N/A
Completed NCT01442753 - Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth N/A
Completed NCT01037868 - Usefulness of Supportive Text Messages in the Treatment of Depressed Alcoholics N/A
Completed NCT00369746 - STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse Phase 4
Recruiting NCT03216954 - Influence of n-Acetylcysteine Maintenance on Alcohol Effects Early Phase 1
Recruiting NCT03575403 - Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate) Phase 1
Not yet recruiting NCT03258632 - Improving Outcomes Among Medical/Surgical Inpatients With Alcohol Use Disorders N/A
Not yet recruiting NCT03701204 - Contingency Management for Alcohol Use Disorder N/A
Not yet recruiting NCT03636555 - Oxytocin Treatment for Alcohol Use Disorders Phase 2